Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

This bill requires all health insurance plans in New Jersey (including hospital, medical, and individual/group plans) to cover the cost of continuous glucose monitoring systems prescribed by doctors for treating glycogen storage disease. It applies to all new or renewed policies on or after the effective date, mandating coverage "to the same extent as for any other medical condition." The law directly affects patients with glycogen storage disease who rely on these monitoring systems for treatment, as well as insurers offering covered health plans in the state. It does not change existing coverage for other conditions but ensures these specific devices are included for this rare metabolic disorder.